Thirty patients suffering from WHO I-II class slight-moderate essential arterial hypertension were treated with a beta-blocker (Penbutolol) alone and once a day to assess its antihypertensive effectiveness and its affect on heart frequency, lipid metabolism and kidney function. The drug proved highly effective in reducing P.A.S. and P.A.D. values and no negative influence was documented on lipid metabolism, kidney function or heart frequency.

Pepe, S., Scalici, G., D'Angelo, A., Curiale, B., Corrao, S., Agnello, C. (1990). Validity of the use of penbutolol in essential arterial hypertension. MINERVA MEDICA, 81(6), 471-473.

Validity of the use of penbutolol in essential arterial hypertension

CORRAO, Salvatore;
1990

Abstract

Thirty patients suffering from WHO I-II class slight-moderate essential arterial hypertension were treated with a beta-blocker (Penbutolol) alone and once a day to assess its antihypertensive effectiveness and its affect on heart frequency, lipid metabolism and kidney function. The drug proved highly effective in reducing P.A.S. and P.A.D. values and no negative influence was documented on lipid metabolism, kidney function or heart frequency.
Settore MED/45 - Scienze Infermieristiche Generali, Cliniche E Pediatriche
Settore MED/09 - Medicina Interna
Settore MED/11 - Malattie Dell'Apparato Cardiovascolare
Pepe, S., Scalici, G., D'Angelo, A., Curiale, B., Corrao, S., Agnello, C. (1990). Validity of the use of penbutolol in essential arterial hypertension. MINERVA MEDICA, 81(6), 471-473.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/121300
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact